Clinical Trial Update: Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing gemcitabine/lobaplatin versus gemcitabine/cisplatin as second-line therapy for metastatic breast cancer, assessing effectiveness and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Harbin Medical University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN